Home > Insider Trading > Filing (0000950170-24-076468)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1936258	Newamsterdam Pharma Co N.v.	NAMS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1573785	H. Michael Davidson	C/O Newamsterdam Pharma Company N.v. Gooimeer 2-35 Naarden P7 1411 DC	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2024-06-20	5,000	$17.26	204,784	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	608,779	Indirect	See footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.115 to $17.60, inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, specific trade amounts and pricing within the range set forth in this footnote at which the transaction was effected.
The 608,779 Ordinary Shares are held of record by Stichting Administratiekantoor EPNAP ("STAK EPNAP") and are subject to forfeiture underlying depositary receipts issued by STAK EPNAP. STAK EPNAP has sole voting and investment power over the 608,779 Ordinary Shares underlying the depositary receipts and are presented here because the depositary receipts can be cancelled by the board of directors of STAK EPNAP at any time as a consequence of which the Reporting Person will become the beneficial owner of the securities underlying the depositary receipts.